BlackRock’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $78.1M | Sell |
|
|||||
|
2023
Q2 | $48.6M | Buy |
|
|||||
|
2023
Q1 | $41.1M | Sell |
|
|||||
|
2022
Q4 | $38.2M | Buy |
|
|||||
|
2022
Q3 | $41M | Buy |
|
|||||
|
2022
Q2 | $37.5M | Buy |
|
|||||
|
2022
Q1 | $43.2M | Buy |
|
|||||
|
2021
Q4 | $36.4M | Sell |
|
|||||
|
2021
Q3 | $35.1M | Buy |
|
|||||
|
2021
Q2 | $46.8M | Sell |
|
|||||
|
2021
Q1 | $56.9M | Sell |
|
|||||
|
2020
Q4 | $61.7M | Buy |
|
|||||
|
2020
Q3 | $90.4M | Sell |
|
|||||
|
2020
Q2 | $114M | Buy |
|
|||||
|
2020
Q1 | $140M | Sell |
|
|||||
|
2019
Q4 | $287M | Sell |
|
|||||
|
2019
Q3 | $155M | Buy |
|
|||||
|
2019
Q2 | $174M | Buy |
|
|||||
|
2019
Q1 | $219M | Sell |
|
|||||
|
2018
Q4 | $205M | Sell |
|
|||||
|
2018
Q3 | $267M | Buy |
|
|||||
|
2018
Q2 | $171M | Buy |
|
|||||
|
2018
Q1 | $78.6M | Buy |
|
|||||
|
2017
Q4 | $69.8M | Buy |
|
|||||
|
2017
Q3 | $67.4M | Buy |
|
|||||
|
2017
Q2 | $138M | Buy |
|
|||||
|
2017
Q1 | $121M | Buy |
|
|||||
|
2016
Q4 | $323K | Sell |
|
|||||
|
2016
Q3 | $534K | Buy |
|
|||||
|
2016
Q2 | $307K | Buy |
|
|||||
|
2016
Q1 | $246K | Buy |
|
|||||
|
2015
Q4 | $71K | Buy |
|
|||||
|
2015
Q3 | $73K | Buy |
|
|||||
|
2015
Q2 | $107K | Buy |
|
|||||
|
2015
Q1 | $106K | Buy |
|
|||||
|
2014
Q4 | $57K | Hold |
|
|||||
|
2014
Q3 | $86K | Hold |
|
|||||
|
2014
Q2 | $86K | Sell |
|
|||||
|
2014
Q1 | $899K | Buy |
|
|||||
|
2013
Q4 | $11K | Hold |
|
|||||
|
2013
Q3 | $12K | Hold |
|
|||||
|
2013
Q2 | $7K | Buy |
|